ABVX

Abivax S.A.

• Reuters·5d ago

  Abivax says JPMorgan Chase beneficial stake rises to 6.2% of capital

• Reuters·5d ago

  UBS Group cuts Abivax stake below 5% to 4.11%

• Reuters·5d ago

  UBS crosses 5% stake, voting rights thresholds in Abivax, holds 5.28% stake

• TipRanks·5d ago

  Abivax appoints Michael Nesrallah as chief commercial officer

• Reuters·5d ago

  Abivax files universal registration document, annual report with French AMF

• Seeking Alpha·6d ago

  Abivax: Obefazimod's Strategic Scarcity Drives Optionality (Maintaining Buy)

• Benzinga·03/31 14:48

  Eli Lilly Expands Into Sleep Medicine With Centessa Buyout

• TipRanks·03/28 14:37

  Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst

• Reuters·03/27 19:16

  Abivax Feb. 28, 2026 issued shares rise to 79.2 million; total voting rights grow to 81.5 million

• Reuters·03/27 11:07

  Abivax notified beneficial ownership; UBS Group drops to 3.23 million shares, 4.11% of capital and 3.99% of voting rights

• Reuters·03/26 16:06

  Abivax notified UBS Group beneficial ownership rises to 4.1 million shares; stake climbs to 5.28% of capital

• TipRanks·03/26 07:39

  Abivax SA (0RA9) Receives a Rating Update from a Top Analyst

• Seeking Alpha·03/25 13:40

  Abivax: Going It Alone At A Premium (Rating Downgrade)

• TipRanks·03/25 10:59

  Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim

• Benzinga·03/24 17:53

  Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears